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Abstract
Background: Tuberculosis poses a great challenge, especially in children. The response of BCG
Test may be different in previously vaccinated children and needs to be considered before
interpreting positivity for TB. This study has been carried out to determine the pattern of BCG
reaction comparing previously vaccinated with non-vaccinated children.
Methods: The study was conducted in the healthy school children aged 4–6 years. The BCG skin
reaction in Mantoux-negative children was compared between children with and without previous
BCG scar. After the Mantoux and BCG Test, the analysis of variance was done as per protocol.
Results: Out of 50 children previously BCG vaccinated, 39(78%) showed exaggerated BCG test
responses while out of another 50 children who were not vaccinated for TB, only 9(18%) showed
exaggerated BCG Test response (p-value < 0.00001). Average induration obtained in children who
were immunized with BCG at birth was much greater than those who were not immunized. 80%
and 76% males and females respectively in Group I showed exaggerated BCG response while 16%
and 20% males and females respectively of Group II showed exaggerated BCG response.
Conclusion:  The present study indicates that normal healthy children may have a mild
exaggerated BCG Test response i.e. induration up to 8 mm because of prior BCG vaccination.
Therefore, BCG Test, though important should not be the only criteria for start of chemotherapy
for TB in children as the side effects of drugs may cause much morbidity. An induration up to 8 mm
after the BCG Test can be normal in Indian settings due to exposure to Mycobacterium in
environment and/or BCG vaccine.
Background
Tuberculosis remains a leading cause of death from any
single infectious disease, accounting for over a quarter of
all avoidable deaths. It infects about 1 billion people and
causing an estimated 1–2 million deaths annually [1].
Nearly 3–4 million children in India have tuberculosis
while 94 million are at risk to infection. 40% of these chil-
dren by the age of 6 yrs and 80% by the age of 16 years are
labeled as infected [2].
Bacillus Calmette-Guerin (BCG) vaccine, which consists
of live attenuated Mycobacterium tubercle bovine Danish
1331 strain, has been extensively used as a protective
measure against tuberculosis for the last half century.
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Under Universal immunization Programme (UIP), pri-
mary BCG vaccination is given at birth or within the first
month. The attenuated bovine non-pathogenic Mycobac-
terium induces tuberculin sensitivity and potentates the
defense mechanism enabling the recipient to combat re-
infection when exposed to pathological strains of myco-
bacterium later. This primary infection enables the vacci-
nated person to mobilize immune processes more rapidly
when challenged by further natural infections.
A definite scar evidences an effective BCG vaccination and
absence of this denotes that no immunity is attributable
to the vaccination [14]. However, even with proper vacci-
nation the immunity has been observed to decline within
a few years, on the basis on which revaccination at five
years has been suggested as an optional dose by the Indian
Academy of Pediatrics [6]. Vijayalakshmi et al[11] sug-
gested that revaccination may be contemplated after 8
years.
BCG given as a diagnostic test is based on Koch's phenom-
enon. When BCG is given to a child with tuberculosis, the
reaction occurs at the site of vaccination within 48–72 hrs
as against the usual late reaction i.e. after 3–6 weeks in
child without tuberculosis. The reaction is measured with
a standard plastic scale and the maximum size of the reac-
tion is noted. The appearance of papule or induration
more than 5 mm in size at the test site is considered as
positive BCG Test [7-11].
BCG Test response is graded as mild (5–10 mm), moder-
ate (10–20 mm) or severe (more than 20 mm) [6]. The
reaction is complete if all the stages i.e. papule, pustule,
ulcer and scab are seen, but is incomplete when only a
papule or nodule is seen and the reaction does not
progress to a stage of pustule or scab formation.
BCG response is more sensitive than the Mantoux test
(Tuberculin test) and hence has been considered a better
tool for epidemiological investigations. However, the
effect of previous BCG vaccine on the subsequent revacci-
nation is not well established and only a few elaborate
studies have been carried out in this regard. It has been
seen that the Mantoux test is not reliable as a post-vacci-
nation check, because in vitro, cell-mediated immune
responses may be demonstrable even when Mantoux test
becomes negative [11,12].
The response of BCG may be different in previously vacci-
nated children and needs to be considered before inter-
preting positivity. The exact type of reaction and range of
induration is not clear cut or well established.
There is possibility of over diagnosis of tuberculosis on
the basis of BCG Test results, if previous BCG vaccination
status is not taken into consideration. It is to be noted that
the BCG Test may be positive in previously vaccinated
children even when Mantoux test is negative.
This study has been carried out to determine the pattern
of BCG reaction comparing previously vaccinated with
non-vaccinated children.
Aims and objectives
1. To assess the BCG skin reaction in Mantoux-negative
healthy children at 4–6 years of age previously vaccinated
with BCG, as evidenced by the presence of scar [14]
2. To compare the reaction between children with and
without previous BCG scar.
Methods
The study was conducted to determine the BCG response
in 100 healthy, Mantoux-negative children in the age
group of 4–6 years in relation to previous vaccination sta-
tus. The informed consent of the parents was taken. Basic
information, including the immunization status, was
obtained on a written proforma from the parents of 193
children of 4–6 yrs age group belonging to kindergarten
schools of urban and rural areas of Ludhiana. The immu-
nization status of the children was confirmed by the pres-
ence of BCG scar[14]. Children with measles or other
serious infections in previous 6 months were excluded.
Also, only those with body weight above 80%of reference
weight (50th percentile of the Harvard standard for the
chronological age) were selected. Children presenting
with clinical features of any disease, including tuberculo-
sis, were excluded.
Mantoux test was given by injecting 0.1 ml (5 TU) of PPD
intradermally on volar surface of left forearm. The test was
read after 48–72 hrs and induration of 5 mm or less was
taken as negative. Those with induration above 5 mm
were excluded. The children were divided into two groups
on the basis of previous BCG vaccination.
Group I: BCG given at birth.
Group II: BCG not given at birth.
The first 25 boys and 25 girls in Group I and Group II each
who fulfilled the above criteria were included in the study.
The children in both groups were given the BCG Test and
the reaction was observed for erythema and induration
after 1 day, 3 days, 7 days and 6 weeks as detailed below.
Children in the Group I with induration 10 mm or more
and in Group II with 6 mm or more were further investi-
gated with x-ray chest to rule out any chance of tuberculo-
sis and thus eliminate false positives in the study.BMC Infectious Diseases 2005, 5:19 http://www.biomedcentral.com/1471-2334/5/19
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BCG test
Freshly diluted freeze-dried 3CC vaccine were mixed. Dry
vaccine and solvent was carried from the refrigerator in an
icebox to the place of vaccination. 0.1 ml of the solution
containing 0.1 mg BCG vaccine was administered intra-
dermally in the deltoid region using sterile disposable
needles.
Observation of Reaction
The reaction was observed after 24 hrs, 72 hrs, one week
and 6 weeks. The horizontal and vertical diameters of
induration were measured. All the measurements were
made by non-stretchable white fiberglass tape measuring
to the nearest of 1 mm. The reactions in the two groups
were recorded.
Results
Out of 50 children in Group I (children who were given
prior BCG vaccination), 39 (i.e. 78 per cent) had exagger-
ated BCG Test responses while in Group II (children who
were not given prior BCG vaccine) only 9 (18 per cent)
out of 50 cases had exaggerated BCG Test response (Refer
to Table 1). Critical difference at 5% of 0.64 and F-ratio of
60.4 indicates high statistically significant difference
between the two groups.
When the exaggerated BCG Test response cases in Group I
were further evaluated for size of the induration, it was
seen that 72% cases had induration between 6 to 8 mm
(Refer to Table 2). Only 2 cases had induration of greater
or equal to 10 mm. These two cases were further investi-
gated with x-ray chest to rule out the possibility of tuber-
culosis. Similarly in Group II, 12% had exaggerated BCG
test response of 6 mm whereas rest 6% had 7 mm
induration.
Almost same number of males and females in both groups
had exaggerated BCG response (Refer to Table 1). No sta-
tistically significant difference was observed between
males and females in either of the two groups.
Highly significant statistical difference of exaggerated
BCG response between Group I (BCG given at birth) and
Group II (BCG not given at birth) were obtained.
To test the significance of this difference of the exagger-
ated response to BCG Test between Group I and Group II,
a Standardized Normal Test for Proportions (Z-Test) was
used. For the calculated value of Z = 7.518, the p-value is
less than 0.00001; thus the exaggerated response of Group
I was found to be highly significant in comparison to that
of Group II.
Discussion
BCG has been extensively used as a protective measure
against tuberculosis for the last half a century [5]. In the
previous two decades encouraging results have been
reported regarding BCG vaccination as a diagnostic test
for tuberculosis and it has been termed BCG Test [3,4].
The effect of previous BCG on subsequent revaccination
response is not well established and only a few elaborate
studies have been carried out in this regard. It has been
seen that Mantoux test is not reliable as a post-vaccination
check; because in-vitro cell mediated immune response
may be demonstrable even when Mantoux test becomes
negative [11,12].
The response of BCG Test may be different in previously
vaccinated children. It needs to be reconsidered before
interpreting postivity. The present study was carried out to
Table 1: Comparison of Exaggerated BCG response in two groups
Number of cases Exaggerated response cases
Study Group Male Female Total Male Female Total
Total % Total % Total %
G r o u p  I 2 52 55 02 08 01 97 53 97 8
Group II 25 25 50 4 16 5 20 9 18
Total 50 50 100 24 48 24 48 48 48
Table 2: Exaggerated BCG response in relation to scar size
Exaggerated response
Scar size Total cases Total %
No scar 50 9 18
Faint scar 27 21 77
Good scar 11 8 72
Large scar 12 10 83BMC Infectious Diseases 2005, 5:19 http://www.biomedcentral.com/1471-2334/5/19
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determine the pattern of BCG reaction comparing previ-
ously vaccinated with non-vaccinated children.
As already mentioned very few studies regarding BCG Test
in prior BCG vaccinated children have been carried out.
One such study is by P.M.Udani[7]: BCG Test in the diag-
nosis of tuberculosis in children – Indian Pediatric,
(1982) addendum regarding "BCG Test in children who
have received prior BCG is available." In this study he
arrived at three sets of conclusions.
First
Negative BCG Test: the infant or child may not get any
reaction because of BCG vaccination and body behaves as
if no prior immunization was given. The prior BCG vac-
cine given at birth did not contribute to immune response
of the child.
Second
Strongly positive BCG Test, a classical accelerated reac-
tion. This reaction is similar to reaction seen in a patient
having tuberculous disease.
Third
Mildly positive reaction. The child may get induration
between 6–9 mm in this reaction. He attributed the third
type of reaction because of prior BCG vaccination.
In the present study, most (about 84%) of the exaggerated
BCG Test response in Group I had reaction between 6–8
mm similar to the Third type of reaction evidenced by
Udani[7]. In the study conducted by Udani[7], no inclu-
sion and exclusion criteria for study have been men-
tioned, and probably all children who were given prior
BCG vaccination were included in the study. As men-
tioned earlier the present study compares the results of the
BCG Test in BCG vaccinated children with BCG non-vac-
cinated children.
Although the 50 boys and 50 girls who were included in
this study were not exactly selected on the basis of formal
random sampling procedures, there is little possibility of
bias. Even though there was no entry criterion, except for
the body weight above 80% and exclusion of any case
with any disease process, we understand that the absence
of formal random allocation is a limitation to the study.
However, the highly significant results (p-value <
0.00001) considerably overshadow the limitation.
Diagnosis of TB in children is not easy. Like in adults one
should not always think of Therapeutic Trial in children as
the drugs are very toxic and the side effects like Optic Neu-
ritis cannot be easily diagnosed in children. So Diagnos-
ing and treating TB in Children is a double-edged sword.
These days PCR and other new investigations have
become useful, but they just add to the old regime of
investigation and are not fully predictive of disease on
their own. So coming to a diagnosis of TB in children need
a lot of clinical skills and interpreting the investigations in
the right way.
There is no doubt that in some children it may be difficult
to decide whether BCG Test is positive because of prior
BCG vaccination or due to natural tubercular infection.
Over diagnosis of tuberculosis is usually made by using
exaggerated BCG Test response as a parameter to decide
anti-tubercular therapy in patients in whom otherwise
history, clinical features, tuberculin test sensitivity, x-ray
chest, etc. are not fully suggestive of the Koch's disease.
The present study indicates that normal healthy children
may have a mild exaggerated BCG Test response i.e. indu-
ration up to 8 mm because of prior BCG vaccination.
Therefore, the patients who were immunized with BCG at
birth and tested positive for BCG Test, and in whom other
parameters for diagnosis of tuberculosis are not sugges-
tive, are perhaps receiving unnecessary anti-tubercular
therapy. A positive test may be of value after correlating it
with the age of the child, nutrition, size of tuberculin test
induration, history of contact and symptoms to diagnose
and institute chemotherapy [1].
Conclusion
78% (39 out of 50) of children in Group I (prior BCG vac-
cination given) and 18% (9 out of 50) in Group II (prior
BCG vaccination not given) had exaggerated BCG
response; defined as induration greater than or equal to 6
mm. Statistical difference (p-value<0.00001) between
Group I and Group II was highly significant. 72% of chil-
dren in Group I, who showed exaggerated BCG response,
had induration in range of 6–8 mm. Only 6% of children
showed induration of 9, 10 or more than 10 mm. 22% of
children in Group I had induration less than 6 mm. Chil-
dren in Group II showing exaggerated BCG response had
induration of either 6 or 7 mm. Differences between male
and female readings in each of two groups were statisti-
cally insignificant. Day 1 and 3 readings were statistically
more significant as compared to day 7 and 6-week read-
ings. All children in Group II showing exaggerated BCG
response and in Group I showing induration of 10 mm or
more were investigated with x-ray chest to rule out tuber-
culosis. Even in absence of prior BCG vaccination, some
normal healthy children of Group II exhibited mildly
exaggerated BCG response. This can probably be
explained on the basis of tubercular infection not warrant-
ing treatment. Significant number (78%) of normal chil-
dren with previous BCG vaccination, who were Mantoux
negative and received BCG as a 'diagnostic test' or as revac-
cination, showed, exaggerated BCG response. Since these
children are healthy, an exaggerated BCG response in suchPublish with BioMed Central    and   every 
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a situation must not be construed as an evidence of tuber-
cular disease.
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